Locana Funding & Investors
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
locanabio.comTotal Amount Raised: $155,550,000
Locana Funding Rounds
Series B
$100,000,000
Series B Investors
Vida VenturesLightstone VenturesLeerink PartnersInvus GroupAcuta Capital PartnersArch Venture PartnersTemasekRA Capital ManagementGVUCB VenturesGrant
$550,000
Grant Investors
Muscular Dystrophy AssociationSeries A
$55,000,000
Series A Investors
Lightstone VenturesArch Venture PartnersTemasekGVUCB Ventures
Funding info provided by Diffbot.